Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease.
Article in Cardiovascular Research (June 2022)
The most recent citing publications are shown below. View all 89 publications that cite this research output on Dimensions.
Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study
Article in PLOS Medicine (June 2022)
Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment
Article in Vaccine (June 2022)